(+)-catechin multiple interactions ISO RGD:1603377 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of HOPX mRNA CTD PMID:24763279 1,2-dichloroethane decreases expression ISO RGD:1557434 6480464 ethylene dichloride results in decreased expression of HOPX mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1557434 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HOPX mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of HOPX mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:1603377 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HOPX mRNA CTD PMID:19619570 17beta-estradiol affects expression ISO RGD:1603377 6480464 Estradiol affects the expression of HOPX mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1603377 6480464 Estradiol results in increased expression of HOPX mRNA CTD PMID:20106945 17beta-estradiol decreases expression ISO RGD:1603377 6480464 Estradiol results in decreased expression of HOPX mRNA CTD PMID:19619570 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1557434 6480464 Tetrachlorodibenzodioxin results in decreased expression of HOPX mRNA CTD PMID:19933214 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HOPX mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HOPX mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1557434 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HOPX mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1603377 6480464 Tetrachlorodibenzodioxin results in decreased expression of HOPX mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1603377 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HOPX mRNA CTD PMID:19619570 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of HOPX mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of HOPX mRNA CTD PMID:25380136 , PMID:30723492 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1557434 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of HOPX mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:1557434 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of HOPX mRNA CTD PMID:33297965 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of HOPX mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:1557434 6480464 Fenretinide results in increased expression of HOPX mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of HOPX mRNA CTD PMID:24780913 more ... acetamide increases expression EXP 6480464 acetamide results in increased expression of HOPX mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1603377 6480464 Aflatoxin B1 affects the expression of HOPX protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1603377 6480464 Aflatoxin B1 results in decreased methylation of HOPX gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1603377 6480464 Tretinoin results in increased expression of HOPX mRNA CTD PMID:16249480 all-trans-retinoic acid multiple interactions ISO RGD:1603377 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of HOPX mRNA CTD PMID:35267148 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of HOPX mRNA CTD PMID:34757178 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HOPX mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of HOPX mRNA CTD PMID:30779732 antimonite multiple interactions ISO RGD:1603377 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA CTD PMID:32076005 antirheumatic drug decreases expression ISO RGD:1603377 6480464 Antirheumatic Agents results in decreased expression of HOPX mRNA CTD PMID:24449571 Archazolid B decreases expression ISO RGD:1603377 6480464 archazolid B results in decreased expression of HOPX mRNA CTD PMID:25218289 arsane multiple interactions ISO RGD:1603377 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HOPX mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1603377 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HOPX mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:1603377 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of HOPX mRNA CTD PMID:32076005 arsenous acid decreases expression ISO RGD:1603377 6480464 Arsenic Trioxide results in decreased expression of HOPX mRNA CTD PMID:26705709 arsenous acid increases expression ISO RGD:1603377 6480464 Arsenic Trioxide results in increased expression of HOPX mRNA CTD PMID:22521957 benzo[a]pyrene increases expression ISO RGD:1603377 6480464 Benzo(a)pyrene results in increased expression of HOPX mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1603377 6480464 Benzo(a)pyrene results in increased methylation of HOPX promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1603377 6480464 Benzo(a)pyrene affects the methylation of HOPX 5' UTR CTD PMID:27901495 beta-naphthoflavone decreases expression ISO RGD:1603377 6480464 beta-Naphthoflavone results in decreased expression of HOPX mRNA CTD PMID:32858204 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1557434 6480464 Diethylhexyl Phthalate results in decreased expression of HOPX mRNA CTD PMID:28085963 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1603377 6480464 Diethylhexyl Phthalate results in increased expression of HOPX mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HOPX mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1557434 6480464 bisphenol A results in decreased expression of HOPX mRNA CTD PMID:33221593 bisphenol A affects methylation ISO RGD:1557434 6480464 bisphenol A affects the methylation of HOPX promoter CTD PMID:27334623 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of HOPX gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HOPX mRNA CTD PMID:30816183 butanal increases expression ISO RGD:1603377 6480464 butyraldehyde results in increased expression of HOPX mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of HOPX mRNA CTD PMID:19167457 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of HOPX mRNA CTD PMID:25993096 carbon nanotube decreases expression ISO RGD:1557434 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1557434 6480464 Nanotubes, Carbon analog results in increased expression of HOPX mRNA CTD PMID:25620056 CHIR 99021 multiple interactions ISO RGD:1603377 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of HOPX mRNA CTD PMID:35267148 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of HOPX mRNA CTD PMID:27523638 curcumin increases expression EXP 6480464 Curcumin results in increased expression of HOPX mRNA CTD PMID:18299980 cyclosporin A increases expression ISO RGD:1603377 6480464 Cyclosporine results in increased expression of HOPX mRNA CTD PMID:20106945 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of HOPX mRNA CTD PMID:20032058 dexamethasone decreases expression ISO RGD:1557434 6480464 Dexamethasone results in decreased expression of HOPX mRNA CTD PMID:22733784 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of HOPX mRNA] CTD PMID:20032058 diarsenic trioxide decreases expression ISO RGD:1603377 6480464 Arsenic Trioxide results in decreased expression of HOPX mRNA CTD PMID:26705709 diarsenic trioxide increases expression ISO RGD:1603377 6480464 Arsenic Trioxide results in increased expression of HOPX mRNA CTD PMID:22521957 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:1603377 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA CTD PMID:32076005 diuron increases expression EXP 6480464 Diuron results in increased expression of HOPX mRNA CTD PMID:25152437 diuron decreases expression EXP 6480464 Diuron results in decreased expression of HOPX mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1603377 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1603377 6480464 Doxorubicin results in decreased expression of HOPX mRNA CTD PMID:30031762 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of HOPX mRNA CTD PMID:29391264 folic acid multiple interactions ISO RGD:1557434 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HOPX mRNA CTD PMID:22206623 genistein increases methylation EXP 6480464 Genistein results in increased methylation of HOPX gene CTD PMID:28505145 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HOPX mRNA CTD PMID:22061828 isoprenaline decreases expression ISO RGD:1557434 6480464 Isoproterenol results in decreased expression of HOPX mRNA CTD PMID:20003209 ketamine increases expression EXP 6480464 Ketamine results in increased expression of HOPX mRNA CTD PMID:20080153 lead diacetate increases expression ISO RGD:1557434 6480464 lead acetate results in increased expression of HOPX mRNA CTD PMID:21829687 lipopolysaccharide multiple interactions ISO RGD:1603377 6480464 [S-(1 more ... CTD PMID:28070326 , PMID:35811015 lipopolysaccharide affects expression ISO RGD:1603377 6480464 Lipopolysaccharides affects the expression of HOPX mRNA CTD PMID:28070326 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of HOPX mRNA CTD PMID:34757178 methylmercury chloride decreases expression ISO RGD:1603377 6480464 methylmercuric chloride results in decreased expression of HOPX mRNA CTD PMID:23179753 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1557434 6480464 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of HOPX mRNA CTD PMID:25566086 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HOPX mRNA CTD PMID:28801915 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of HOPX mRNA CTD PMID:25380136 N-Nitrosopyrrolidine increases expression ISO RGD:1603377 6480464 N-Nitrosopyrrolidine results in increased expression of HOPX mRNA CTD PMID:32234424 nitrofen multiple interactions ISO RGD:1557434 6480464 [nitrofen co-treated with N more ... CTD PMID:30995255 p-chloromercuribenzoic acid decreases expression ISO RGD:1603377 6480464 p-Chloromercuribenzoic Acid results in decreased expression of HOPX mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1603377 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HOPX mRNA CTD PMID:27188386 phenobarbital affects expression ISO RGD:1557434 6480464 Phenobarbital affects the expression of HOPX mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1603377 6480464 Phenylmercuric Acetate results in decreased expression of HOPX mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1603377 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HOPX mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1557434 6480464 pirinixic acid results in increased expression of HOPX mRNA CTD PMID:18301758 pirinixic acid decreases expression ISO RGD:1557434 6480464 pirinixic acid results in decreased expression of HOPX mRNA CTD PMID:17426115 , PMID:23811191 pravastatin decreases expression ISO RGD:1557434 6480464 Pravastatin results in decreased expression of HOPX mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of HOPX mRNA CTD PMID:27225895 progesterone affects expression ISO RGD:1557434 6480464 Progesterone affects the expression of HOPX mRNA CTD PMID:17251523 progesterone increases expression EXP 6480464 Progesterone results in increased expression of HOPX mRNA CTD PMID:20726854 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of HOPX mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of HOPX mRNA CTD PMID:25905778 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1603377 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of HOPX mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1603377 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate multiple interactions ISO RGD:1603377 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HOPX mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1603377 6480464 sodium arsenite results in increased expression of HOPX mRNA CTD PMID:29301061 sodium arsenite multiple interactions ISO RGD:1603377 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of HOPX mRNA CTD PMID:32076005 Soman increases expression EXP 6480464 Soman results in increased expression of HOPX mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of HOPX mRNA CTD PMID:25905778 sunitinib decreases expression ISO RGD:1603377 6480464 Sunitinib results in decreased expression of HOPX mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:1557434 6480464 Tamoxifen results in increased expression of HOPX mRNA CTD PMID:25123088 temozolomide decreases expression ISO RGD:1603377 6480464 Temozolomide results in decreased expression of HOPX mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of HOPX mRNA] CTD PMID:20032058 tetrachloromethane decreases expression ISO RGD:1557434 6480464 Carbon Tetrachloride results in decreased expression of HOPX mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HOPX mRNA CTD PMID:34492290 triazines multiple interactions ISO RGD:1557434 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of HOPX mRNA] CTD PMID:27469509 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of HOPX mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1603377 6480464 trichostatin A results in increased expression of HOPX mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1603377 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOPX mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1603377 6480464 Triclosan results in decreased expression of HOPX mRNA CTD PMID:30510588 triptonide decreases expression ISO RGD:1557434 6480464 triptonide results in decreased expression of HOPX mRNA CTD PMID:33045310 valproic acid decreases methylation ISO RGD:1603377 6480464 Valproic Acid results in decreased methylation of HOPX gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1603377 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOPX mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1603377 6480464 Valproic Acid results in increased expression of HOPX mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1603377 6480464 Valproic Acid affects the expression of HOPX mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of HOPX mRNA CTD PMID:19015723 WIN 18446 multiple interactions ISO RGD:1557434 6480464 [nitrofen co-treated with N more ... CTD PMID:30995255 zinc atom decreases expression ISO RGD:1603377 6480464 Zinc deficiency results in decreased expression of HOPX mRNA CTD PMID:22171008 zinc(0) decreases expression ISO RGD:1603377 6480464 Zinc deficiency results in decreased expression of HOPX mRNA CTD PMID:22171008